Matrix metalloproteinases in vascular disease--a potential therapeutic target?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Vascular Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/157016110790226697PMID 19485936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins.

  2008cited by this paper
• Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms

  2008cited by this paper
• The inhibition of matrix metalloproteinase activity in chronic wounds by a polyacrylate superabsorber.

  2008cited by this paper
• Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration

  2008cited by this paper
• Experimental models of abdominal aortic aneurysms: an overview.

  2008cited by this paper
• Are Statins an Option in the Management of Abdominal Aortic Aneurysms?

  2008cited by this paper
• Mechanisms of varicose vein formation: valve dysfunction and wall dilation

  2008cited by this paper
• Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm.

  2008cited by this paper
• Effect of collagen turnover and matrix metalloproteinase activity on healing of venous leg ulcers

  2008cited by this paper
• Induction of MMP‐1, MMP‐3 and TIMP‐1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid *

  2008cited by this paper
• MMPs as therapeutic targets--still a viable option?

  2008cited by this paper
• The relationship between cytokine concentrations and wound healing in chronic venous ulceration.

  2008cited by this paper
• Evaluation of the nano‐oligosaccharide factor lipido‐colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial

  2008cited by this paper
• Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

  2008cited by this paper
• A randomized, placebo-controlled trial of doxycycline after endoluminal aneurysm repair.

  2008cited by this paper
• Insight into the structural determinants for selective inhibition of matrix metalloproteinases.

  2007cited by this paper
• Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis?

  2007cited by this paper
• Primary chronic venous disorders.

  2007cited by this paper
• Murine macrophage P2X7 receptors support rapid prothrombotic responses.

  2007cited by this paper
• Smoking and aortic diseases.

  2007cited by this paper
• Matrix metalloproteinases in peripheral vascular disease.

  2007cited by this paper
• Matrix metalloproteases: Underutilized targets for drug delivery

  2007cited by this paper
• Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor‐bearing microparticles

  2007cited by this paper
• Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes?

  2007cited by this paper
• Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation.

  2007cited by this paper
• Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor.

  2006cited by this paper
• Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices.

  2006cited by this paper
• The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.

  2006cited by this paper
• The Histopathology of Varicose Vein Disease

  2006cited by this paper
• Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth.

  2006cited by this paper
• Expression of matrix metalloproteinase (MMP)‐7 and MMP‐13 and loss of MMP‐19 and p16 are associated with malignant progression in chronic wounds

  2005cited by this paper
• Matrix Metalloproteinase-8 and -9 Are Increased at the Site of Abdominal Aortic Aneurysm Rupture

  2005cited by this paper
• An animal model of venous hypertension: the role of inflammation in venous valve failure.

  2005cited by this paper
• Suppression of Experimental Aortic Aneurysms: Comparison of Inducible Nitric Oxide Synthase and Cyclooxygenase Inhibitors

  2005cited by this paper
• Combination therapy of doxycycline and topical tacrolimus for venous ulcers.

  2005cited by this paper
• Effect of Chronic Wound Exudates and MMP-2/-9 Inhibitor on Angiogenesis In Vitro

  2005cited by this paper
• Decreased Production of Collagen Type III in Cultured Smooth Muscle Cells from Varicose Vein Patients Is due to a Degradation by MMPs: Possible Implication of MMP-3

  2005cited by this paper
• HMG-CoA Reductase Inhibitors Reduce Matrix Metalloproteinase-9 Activity in Human Varicose Veins

  2005cited by this paper
• Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis.

  2004cited by this paper
• Inward Remodeling of the Rabbit Aorta Is Blocked by the Matrix Metalloproteinase Inhibitor Doxycycline

  2004cited by this paper
• Matrix metalloproteinases in the vein wall.

  2004cited by this paper
• Hypertension-induced venous valve remodeling.

  2004cited by this paper
• A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.

  2003cited by this paper
• Matrix Metalloproteinase-9 and Urokinase-type Plasminogen Activator in Varicose Veins

  2003cited by this paper
• Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease

  2003cited by this paper
• Morphologic characteristics of varicose veins: possible role of metalloproteinases.

  2003cited by this paper
• A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening.

  2003cited by this paper
• Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds.

  2002cited by this paper
• Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury.

  2002cited by this paper
• Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Molecular physiology of P2X receptors.

  2002cited by this paper
• Plasma Matrix Metalloproteinase-9 as a Marker of Blood Stasis in Varicose Veins

  2002cited by this paper
• Strategies for MMP inhibition in cancer: innovations for the post-trial era

  2002cited by this paper
• Gene Transfer of the Urokinase-Type Plasminogen Activator Receptor-Targeted Matrix Metalloproteinase Inhibitor TIMP-1.ATF Suppresses Neointima Formation More Efficiently Than Tissue Inhibitor of Metalloproteinase-1

  2002cited by this paper
• Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

  2002cited by this paper
• Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane‐type matrix metalloproteinases in venous leg ulcers

  2002cited by this paper
• Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13.

  2002cited by this paper
• Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.

  2001cited by this paper
• Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression.

  2001cited by this paper
• Collagen alteration in vascular remodeling by hemodynamic factors

  2000cited by this paper
• Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease.

  2000cited by this paper
• Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption.

  2000cited by this paper
• Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation

  2000cited by this paper
• CD39 Modulates Endothelial Cell Activation and Apoptosis

  2000cited by this paper
• Effect of Matrix Metalloproteinase Inhibition on Progression of Atherosclerosis and Aneurysm in LDL Receptor‐Deficient Mice Overexpressing MMP‐3, MMP‐12, and MMP‐13 and on Restenosis in Rats after Balloon Injury

  1999cited by this paper
• Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release.

  1999cited by this paper
• Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms.

  1999cited by this paper
• The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms.

  1999cited by this paper
• Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing.

  1999cited by this paper
• The influence of indomethacin on the metabolism and cytokine secretion of human aneurysmal aorta.

  1999cited by this paper
• Uptake of tetracycline by aortic aneurysm wall and its effect on inflammation and proteolysis

  1999cited by this paper
• Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model.

  1998cited by this paper
• Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins

  1998cited by this paper
• Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

  1998cited by this paper
• Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis.

  1998cited by this paper
• Tissue inhibitor of metalloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the leg.

  1998cited by this paper
• Metalloproteinase blockade by local overexpression of TIMP-1 increases elastin accumulation in rat carotid artery intima.

  1998cited by this paper
• Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation.

  1998cited by this paper
• Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.

  1998cited by this paper
• Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm.

  1997cited by this paper
• Size matters: the relationship between MMP-9 expression and aortic diameter.

  1997cited by this paper
• Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

  1997cited by this paper
• Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells.

  1997cited by this paper
• Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds.

  1997cited by this paper
• The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration.

  1996cited by this paper
• Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo.

  1996cited by this paper
• Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries.

  1996cited by this paper
• MMP-2: expression, activation and inhibition.

  1996cited by this paper
• Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.

  1995cited by this paper
• In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta.

  1995cited by this paper
• Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery.

  1994cited by this paper
• Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall.

  1994cited by this paper
• Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat.

  1994cited by this paper
• Elastase activity: the role of elastase in aortic aneurysm formation.

  1982cited by this paper
• Collagenase activity of the human aorta. A comparison of patients with and without abdominal aortic aneurysms.

  1980cited by this paper

• Nanoparticle-enabled plasma proteomics of a mouse atherosclerosis model

  2025cites this paper
• An Artificial Intelligence-Based Digital Analysis of Immunolocalization of MMP2 and TIMP2 in the Jejunum of Rats Treated with Calcineurin Inhibitors

  2024cites this paper
• Osteoarthrosis of the knee joints or varicose veins of the lower extremities: Which comes first?

  2024cites this paper
• Migraine: Advances in the Pathogenesis and Treatment

  2023influential citation
• The Effect of Chronic Immunosuppressive Regimens Treatment on Aortal Media Morphology and the Balance between Matrix Metalloproteinases (mmp-2 and mmp-9) and Their Inhibitors in the Abdominal Aorta of Rats

  2022cites this paper
• Varicose Veins

  2022cites this paper
• Data mining reveal the association between diabetic foot ulcer and peripheral artery disease

  2022cites this paper
• Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases

  2021cites this paper
• Signaling pathways associated with structural changes in varicose veins: a case–control study

  2021cites this paper
• Cytokines in Pathogenesis of Varicose Veins

  2021cites this paper
• Construction of fuzzy inference rules for medicine diagnostics problems

  2021cites this paper
• Study of association of varicose veins and inflammation by inflammatory markers

  2020cites this paper
• The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients

  2020cites this paper
• The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?

  2020cites this paper
• Imbalance in matrix metalloproteinases and tissue inhibitor of metalloproteinases from splenic veins and great saphenous veins under high hemodynamics

  2020cites this paper
• Disequilibrium in MMPs and the tissue inhibitor of metalloproteinases in different segments of the varicose great saphenous vein wall.

  2019cites this paper
• The association of matrix metalloproteinases polymorphisms and interleukins in advanced age-related macular degeneration

  2018influential citation
• Polymorphism of Matrix Metalloproteinases Genes MMP1, MMP2, MMP3, and MMP7 and the Risk of Varicose Veins of Lower Extremities

  2017cites this paper
• Protease activity as a prognostic factor for wound healing in venous leg ulcers.

  2017cites this paper
• MicroRNA-mediated MMP Regulation: Current Diagnostic and Therapeutic Strategies for Metabolic Syndrome.

  2017cites this paper
• Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP‐2, MMP‐9, MMP‐12) and their inhibitor TIMP‐2

  2017cites this paper
• Molecular Mechanisms Underlying the Development of Varicose Veins of Low Extremities

  2017cites this paper
• Influence of Matrix Metalloproteinases MMP-2, -3 and on Age- Related Macular Degeneration Development

  2017cites this paper
• Effects of cigarette smoking on cardiovascular-related protein profiles in two community-based cohort studies.

  2016cites this paper
• Reactive oxygen species and bacterial biofilms in diabetic wound healing.

  2016cites this paper
• Exercise suppresses COX-2 pro-inflammatory pathway in vestibular migraine.

  2015cites this paper
• Synthesis, X-ray crystal structure and biological evaluation of zinc(II)-dichlorido complexes with 9-deazahypoxathine derivatives

  2015cites this paper
• Chronic Venous Insufficiency and Venous Ulcers: Pathophysiology

  2015cites this paper
• The Role of Matrix Metalloproteinases Polymorphisms in Age-Related Macular Degeneration

  2015cites this paper
• Role of functional imaging in determining inflammation and extracellular matrix degradation in aortic aneurysms

  2015cites this paper
• Epidemiology and Risk Factors

  2015cites this paper
• Effect of Micronized Purified Flavonoid Fraction Therapy on Endothelin-1 and TNF-α Levels in Relation to Antioxidant Enzyme Balance in the Peripheral Blood of Women with Varicose Veins.

  2015cites this paper
• MMP 9 Gene Polymorphism is not Associated with Polypoidal Choroidal Vasculopathy and Neovascular Age-related Macular Degeneration in a Chinese Han Population

  2014cites this paper
• SELECTION OF AN EFFICIENT CHONDROITIN SULFATE-LIPOSOME DELIVERY SYSTEM AS CHONDROPROTECTIVE AGENT FOR LOCAL INFLAMMATION TREATMENT

  2014cites this paper
• MMP9 Gene Polymorphism is not Associated with Polypoidal Choroidal Vasculopathy and Neovascular Age-related Macular Degeneration in a Chinese Han Population

  2014cites this paper
• FRET‐based and other fluorescent proteinase probes

  2014cites this paper
• Lipid: Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes

  2014cites this paper
• An RCT of clinical and cost effectiveness of endovenous laser therapy in the treatment of varicose veins secondary to isolated saphenopopliteal incompetence and small saphenous reflux

  2014influential citation
• TISSUE INHIBITOR OF METALLOPROTEINASE)1 (TIMP)1) AS AN INDEPENDENT MARKER OF ISCHEMIC MYOCARDIAL REMODELING IN HEART FAILURE

  2014cites this paper
• Metalloproteinases and metalloproteinase inhibitors in age-related diseases.

  2014cites this paper
• An impact of mutation on MMP-2, -3 and -9 activity regulation and influence on age-related macular degeneration development: literature review

  2014cites this paper
• Expression levels of elastin and related genes in human varicose veins.

  2014cites this paper
• The effects of antiepileptic drugs on vascular risk factors: a narrative review.

  2014cites this paper
• Metalloproteinases in Acute Venous Occlusion

  2013influential citation
• Combined Nutraceutical Approach to Postmenopausal Syndrome and Vascular Remodeling Biomarkers

  2013cites this paper
• Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration

  2013cites this paper
• Biomarkers Associated With Migraine and Their Potential Role in Migraine Management

  2013cites this paper
• Cyclophilin-A: a novel biomarker for untreated male essential hypertension

  2013cites this paper
• Traitement conservateur de la maladie veineuse chronique : l'expérience italienne. Conservative treatment of chronic venous disease: the Italian experience.

  2013cites this paper
• Chapter 153 – Neutrophil Collagenase

  2013cites this paper
• Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation

  2013cites this paper
• Optimising outcomes in the treatment of lower limb varicose veins

  2012cites this paper
• Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.

  2012cites this paper
• The effect of interleukin and matrix metalloproteinase on the vulnerability of carotid atherosclerotic plaque and cerebral infarction

  2012cites this paper
• Nuclear localization of matrix metalloproteinases.

  2012cites this paper
• Oral doxycycline with topical tacrolimus for treatment of stasis dermatitis due to chronic venous insufficiency: A pilot study

  2012cites this paper
• An updated patent therapeutic agents targeting MMPs.

  2012cites this paper
• Atorvastatin and Simvastatin, but not Pravastatin, Up-regulate LPS-Induced MMP-9 Expression in Macrophages by Regulating Phosphorylation of ERK and CREB

  2012cites this paper
• Matrix metalloproteinases in acute coronary syndromes: current perspectives.

  2012cites this paper
• Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.

  2012cites this paper
• Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men

  2012cites this paper
• Pathogenesis of varicose veins.

  2012cites this paper
• Emodin inhibits tumor necrosis factor-α-induced migration and inflammatory responses in rat aortic smooth muscle cells.

  2012cites this paper
• Deletion of a tumor necrosis superfamily gene in mice leads to impaired healing that mimics chronic wounds in humans

  2012cites this paper
• The Effect of Pressure-Induced Mechanical Stretch on Vascular Wall Differential Gene Expression

  2012cites this paper
• Chemical Biology for Understanding Matrix Metalloproteinase Function

  2012cites this paper
• Statins and noncardiac vascular disease

  2012cites this paper
• Inflammation in hypertension: current therapeutic approaches.

  2011cites this paper
• Author ' s personal copy Pharmacological Treatment of Primary Chronic Venous Disease : Rationale , Results and Unanswered Questions

  2011cites this paper
• Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions.

  2011cites this paper
• [Medical treatment of chronic venous disease: evolution or involution?].

  2011cites this paper
• Determining the effectiveness of inelastic short stretch bandages in sustaining sub-bandage graduated compression

  2011cites this paper
• Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

  2011cites this paper
• The role of endovenous thermal ablation in the treatment of varicose veins

  2011cites this paper
• Vascular progenitor cells in arterial remodeling

  2011cites this paper
• Lipid metabolism and osteoarthritis: lessons from atherosclerosis.

  2011cites this paper
• Matrix metalloproteinase-9 vs. troponin T. The sooner the better?

  2011cites this paper
• Hypoxia-inducible factor-1 in arterial disease: a putative therapeutic target.

  2011cites this paper
• Matrix Metalloproteinase-9 vs. Troponin T

  2011cites this paper
• MMP2 gene polymorphisms and MMP2 mRNA levels in patients with superficial varices of lower extremities.

  2011cites this paper
• RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima

  2010cites this paper
• Natural history and progression of primary chronic venous disorder.

  2010cites this paper
• Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava.

  2010cites this paper
• Venous Hypoxia: A Poorly Studied Etiological Factor of Varicose Veins

  2010cites this paper
• Matrix metalloproteinases – an overview

  2010cites this paper
• Pathogenesis of primary varicose veins

  2009cites this paper